Post-antibiotic era in hemodialysis? Two case reports of simultaneous colonization and bacteremia by multidrug-resistant bacteria
Open Access
- 1 December 2021
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 43 (4) , 597-602
Abstract
The emergence of resistance mechanisms not only limits the therapeutic options for common bacterial infections but also worsens the prognosis in patients who have conditions that increase the risk of bacterial infections. Thus, the effectiveness of important medical advances that seek to improve the quality of life of patients with chronic diseases is threatened. We report the simultaneous colonization and bacteremia by multidrug-resistant bacteria in two hemodialysis patients. The first patient was colonized by carbapenem- and colistin-resistant Klebsiella pneumoniae, carbapenem-resistant Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus (MRSA). The patient had a bacteremia by MRSA, and molecular typing methods confirmed the colonizing isolate was the same strain that caused infection. The second case is of a patient colonized by extended-spectrum beta-lactamases (ESBL)-producing Escherichia coli and carbapenem-resistant Pseudomonas aeruginosa. During the follow-up period, the patient presented three episodes of bacteremia, one of these caused by ESBL-producing E. coli. Molecular methods confirmed colonization by the same clone of ESBL-producing E. coli at two time points, but with a different genetic pattern to the strain isolated from the blood culture. Colonization by multidrug-resistant bacteria allows not only the spread of these microorganisms, but also increases the subsequent risk of infections with limited treatments options. In addition to infection control measures, it is important to establish policies for the prudent use of antibiotics in dialysis units.Keywords
This publication has 17 references indexed in Scilit:
- Body Site Staphylococcus aureus Colonization among Maintenance Hemodialysis PatientsNephron, 2015
- Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteriaAdvanced Drug Delivery Reviews, 2014
- Meta-Analysis of Methicillin-Resistant Staphylococcus aureus Colonization and Risk of Infection in Dialysis PatientsJournal of the American Society of Nephrology, 2014
- Antibiotics and Bacterial Resistance in the 21st CenturyPerspectives in Medicinal Chemistry, 2014
- Multidrug‐Resistant Organisms in Dialysis PatientsSeminars in Dialysis, 2013
- Persistent nasal methicillin-resistant staphylococcus aureus carriage in hemodialysis outpatients: a predictor of worse outcomeBMC Nephrology, 2013
- Novel antimicrobial-resistant bacteria among patients requiring chronic hemodialysisCurrent Opinion in Nephrology and Hypertension, 2012
- Investigating the impact of the definition of previous antibiotic exposure related to isolation of extended spectrum β-Lactamase-producing Klebsiella pneumoniaeAmerican Journal of Infection Control, 2011
- Multidrug-Resistant Gram-Negative Bacteria among Patients Who Require Chronic HemodialysisClinical Journal of the American Society of Nephrology, 2008
- Serious Consequences to the Use of Cephalosporins as the First Line of Antimicrobial Therapy Administered in Hemodialysis UnitsNephron Clinical Practice, 2005